Somayeh Shokri

Dr. Somayeh Shokri


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2021 in Scandinavian Journal of Immunology
Verified
Journal Article
Open access
PDF file
SMShahab Mahmoudvand
Shahab Mahmoudvand
SSSomayeh Shokri
Somayeh Shokri
Coronaviruses (CoVs) are a large family of respiratory viruses which can cause mild to moderate upper respiratory tract infections. Recently, new coronavirus named as Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been identified which is a major threat to public health. Innate immune responses play a vital role in a host's defence against viruses. Interestingly, CoVs have evolved elaborate strategies to evade the complex system of sensors and signalling molecules to suppress host immunity. SARS‐CoV‐2 papain‐like protease (PLpro), as an important coronavirus enzyme, regulates viral spread and innate immune responses. SCoV‐2 PLpro is multifunctional enzyme with deubiquitinating (DUB) and deISGylating activity. The PLpro can interact with key regulators in signalling pathways such as STING, NF‐κB, cytokine production, MAPK and TGF‐β and hijack those to block the immune responses. Therefore, the PLpro can be as an important target for the treatment of COVID‐19. Until now, several drugs or compounds have been identified that can inhibit PLpro activity. Here we discuss about the dysregulation effects of PLpro on immune system and drugs that have potential inhibitors for SCoV‐2 PLpro.

12 July 2021 in Reviews in Medical Virology
Verified
Journal Article
Open access
PDF file
MKMina Mobini Kesheh
Mina Mobini Kesheh
SMShahab Mahmoudvand
Shahab Mahmoudvand
SSSomayeh Shokri
Somayeh Shokri
Long noncoding RNAs (lncRNAs) are defined as RNA molecules longer than 200 nucleotides that can regulate gene expression at the transcriptional or post‐transcriptional levels. Both human lncRNAs and lncRNAs encoded by viruses can modulate the expression of host genes which are critical for viral replication, latency, activation of signalling pathways, cytokine and chemokine production, RNAi processing, expression of interferons (IFNs) and interferon‐stimulated genes (ISGs). Studies on lncRNAs as key regulators of host‐virus interactions may give new insights into therapeutic strategies for the treatment of related diseases. This current review focuses on the role of lncRNAs, and their interactions with respiratory viruses including influenza A virus (IAV), respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2).

1 February 2019 in Journal of Virological Methods
Verified
Journal Article
Closed access
SSSomayeh Shokri
Somayeh Shokri
MSMohammad Kazem Shahkarami
Mohammad Kazem Shahkarami
ASAbbas Shafyi
Abbas Shafyi
AMAshraf Mohammadi
Ashraf Mohammadi
FSFarzaneh Sabahi
Farzaneh Sabahi
AHAmir Hamta
Amir Hamta

15 July 2024 in Infectious Agents and Cancer
Verified
Journal Article
Open access
PDF file
SSSheida Behzadi Sheikhrobat
Sheida Behzadi Sheikhrobat
SMShahab Mahmoudvand
Shahab Mahmoudvand
SKSalva Kazemipour-Khabbazi
Salva Kazemipour-Khabbazi
ZRZahra Ramezannia
Zahra Ramezannia
HBHossein Bannazadeh Baghi
Hossein Bannazadeh Baghi
SSSomayeh Shokri
Somayeh Shokri
Hepatitis B Virus (HBV) is a hepatotropic virus that can establish a persistent and chronic infection in humans. Chronic hepatitis B (CHB) infection is associated with an increased risk of hepatic decompensation, cirrhosis, and hepatocellular carcinoma (HCC). Lactate level, as the end product of glycolysis, plays a substantial role in metabolism beyond energy production. Emerging studies indicate that lactate is linked to patient mortality rates, and HBV increases overall glucose consumption and lactate production in hepatocytes. Excessive lactate plays a role in regulating the tumor microenvironment (TME), immune cell function, autophagy, and epigenetic reprogramming. The purpose of this review is to gather and summarize the existing knowledge of the lactate’s functions in the dysregulation of the immune system, which can play a crucial role in the development of HBV-related HCC. Therefore, it is reasonable to hypothesize that lactate with intriguing functions can be considered an immunomodulatory metabolite in immunotherapy.

26 July 2022 in Journal of Clinical and Translational Hepatology
Verified
Journal Article
Open access
PDF file
SMShahab Mahmoudvand
Shahab Mahmoudvand
SSSomayeh Shokri
Somayeh Shokri

23 January 2024 in Journal of Cancer Metastasis and Treatment
Verified
Journal Article
Open access
PDF file
ASAli Shojaeian
Ali Shojaeian
MNMohsen Nakhaie
Mohsen Nakhaie
ZAZahra Sobhi Amjad
Zahra Sobhi Amjad
ABArmin Khaghani Boroujeni
Armin Khaghani Boroujeni
SSSomayeh Shokri
Somayeh Shokri
SMShahab Mahmoudvand
Shahab Mahmoudvand
Hepatocellular carcinoma (HCC) is categorized among the most common primary malignant liver cancer and a primary global cause of death from cancer. HCC tends to affect males 2-4 times more than females in many nations. The main factors that raise the incidence of HCC are chronic liver diseases, hepatotropic viruses like hepatitis B (HBV) and C (HCV), non-alcoholic fatty liver disease, exposure to toxins like aflatoxin, and non-alcoholic steatohepatitis (NASH). Among these, hepatitis B and C are the most prevalent causes of chronic hepatitis globally. Metformin, which is made from a naturally occurring compound called galegine, derived from the plant Galega officinalis (G. officinalis), has been found to exhibit antitumor effects in a wide range of malignancies, including HCC. In fact, compared to patients on sulphonylureas or insulin, studies have demonstrated that metformin treatment significantly lowers the risk of HCC in patients with chronic liver disease. This article will first describe the molecular mechanism of hepatitis B and C viruses in the development of HCC. Then, we will provide detailed explanations about metformin, followed by a discussion of the association between metformin and hepatocellular carcinoma caused by the viruses mentioned above.